12-9326-42
antibody from Invitrogen Antibodies
Targeting: EPCAM
17-1A, 323/A3, CD326, CO-17A, EGP-2, EGP34, EGP40, Ep-CAM, ESA, GA733-2, HEA125, KS1/4, KSA, Ly74, M4S1, MH99, MIC18, MK-1, MOC31, TACST-1, TACSTD1, TROP1
Antibody data
- Antibody Data
- Antigen structure
- References [30]
- Comments [0]
- Validations
- Flow cytometry [1]
- Other assay [13]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 12-9326-42 - Provider product page
- Provider
- Invitrogen Antibodies
- Product name
- CD326 (EpCAM) Monoclonal Antibody (1B7), PE, eBioscience™
- Antibody type
- Monoclonal
- Antigen
- Other
- Description
- Description: EpCAM (Epithelial cell adhesion molecule, CD326, KSA, TROP1) is a 40 kD cell-surface adhesion molecule participating in homophilic, calcium-independent cell-cell interactions. EpCAM is a type-I transmembrane protein, and is expressed primarily on the basolateral surface of most epithelia. Although normal epithelia express low levels of EpCAM, increased expression has been correlated with increased proliferation and progression to a mesenchymal phenotype. EpCAM has also been used as a diagnostic marker on circulating metastatic carcinoma cells, while cancer cells of non-epithelial origin do not express EpCAM. Applications Reported: This 1B7 antibody has been reported for use in flow cytometric analysis. Applications Tested: This 1B7 antibody has been pre-titrated and tested by flow cytometric analysis of A549 human lung carcinoma cells. This can be used at 5 µL (0.125 µg) per test. A test is defined as the amount (µg) of antibody that will stain a cell sample in a final volume of 100 µL. Cell number should be determined empirically but can range from 10^5 to 10^8 cells/test. Excitation: 488-561 nm; Emission: 578 nm; Laser: Blue Laser, Green Laser, Yellow-Green Laser. Filtration: 0.2 µm post-manufacturing filtered.
- Reactivity
- Human
- Host
- Mouse
- Conjugate
- Yellow dye
- Isotype
- IgG
- Antibody clone number
- 1B7
- Vial size
- 100 Tests
- Concentration
- 5 µL/Test
- Storage
- 4° C, store in dark, DO NOT FREEZE!
Submitted references Dendritic cell phenotype and function in a 3D co-culture model of patient-derived metastatic colorectal cancer organoids.
Dynamics of CXCR4 positive circulating tumor cells in prostate cancer patients during radiotherapy.
The Effect of Infant Gastric Digestion on Human Maternal Milk Cells.
Tumor suppressor DEAR1 regulates mammary epithelial cell fate and predicts early onset and metastasis in triple negative breast cancer.
The sodium/glucose cotransporters as potential therapeutic targets for CF lung diseases revealed by human lung organoid swelling assay.
EMP3 negatively modulates breast cancer cell DNA replication, DNA damage repair, and stem-like properties.
miR-34a mimic or pre-mir-34a, which is the better option for cancer therapy? KatoIII as a model to study miRNA action in human gastric cancer cells.
Nicotine promotes breast cancer metastasis by stimulating N2 neutrophils and generating pre-metastatic niche in lung.
Targeting Mitochondria-Located circRNA SCAR Alleviates NASH via Reducing mROS Output.
Chemotherapeutic Stress Influences Epithelial-Mesenchymal Transition and Stemness in Cancer Stem Cells of Triple-Negative Breast Cancer.
FZD5 contributes to TNBC proliferation, DNA damage repair and stemness.
Human colorectal cancer cells frequently express IgG and display unique Ig repertoire.
Profiling human breast epithelial cells using single cell RNA sequencing identifies cell diversity.
Evidence of In Vitro Preservation of Human Nephrogenesis at the Single-Cell Level.
TGF-β1 secreted by Tregs in lymph nodes promotes breast cancer malignancy via up-regulation of IL-17RB.
A cell transportation solution that preserves live circulating tumor cells in patient blood samples.
Solitomab, an EpCAM/CD3 bispecific antibody construct (BiTE®), is highly active against primary uterine and ovarian carcinosarcoma cell lines in vitro.
Solitomab, an epithelial cell adhesion molecule/CD3 bispecific antibody (BiTE), is highly active against primary chemotherapy-resistant ovarian cancer cell lines in vitro and fresh tumor cells ex vivo.
The isolation and characterization of CTC subsets related to breast cancer dormancy.
Clostridium perfringens enterotoxin C-terminal domain labeled to fluorescent dyes for in vivo visualization of micrometastatic chemotherapy-resistant ovarian cancer.
NDY1/KDM2B functions as a master regulator of polycomb complexes and controls self-renewal of breast cancer stem cells.
GATA3 suppresses metastasis and modulates the tumour microenvironment by regulating microRNA-29b expression.
Stem-like epithelial cells are concentrated in the distal end of the fallopian tube: a site for injury and serous cancer initiation.
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion, and breast cancer cell dissemination in vivo.
Slow-cycling therapy-resistant cancer cells.
Establishment and characterization of a new human pancreatic adenocarcinoma cell line with high metastatic potential to the lung.
Exploration of target molecules for prostate cancer gene therapy.
Expression of epithelial cell adhesion molecule in carcinoma cells present in blood and primary and metastatic tumors.
Evidence for a role of the epithelial glycoprotein 40 (Ep-CAM) in epithelial cell-cell adhesion.
Ep-CAM: a human epithelial antigen is a homophilic cell-cell adhesion molecule.
Subtil B, Iyer KK, Poel D, Bakkerus L, Gorris MAJ, Escalona JC, van den Dries K, Cambi A, Verheul HMW, de Vries IJM, Tauriello DVF
Frontiers in immunology 2023;14:1105244
Frontiers in immunology 2023;14:1105244
Dynamics of CXCR4 positive circulating tumor cells in prostate cancer patients during radiotherapy.
Klusa D, Lohaus F, Franken A, Baumbach M, Cojoc M, Dowling P, Linge A, Offermann A, Löck S, Hušman D, Rivandi M, Polzer B, Freytag V, Lange T, Neubauer H, Kücken M, Perner S, Hölscher T, Dubrovska A, Krause M, Kurth I, Baumann M, Peitzsch C
International journal of cancer 2023 Jun 15;152(12):2639-2654
International journal of cancer 2023 Jun 15;152(12):2639-2654
The Effect of Infant Gastric Digestion on Human Maternal Milk Cells.
Doerfler R, Melamed JR, Whitehead KA
Molecular nutrition & food research 2022 Oct;66(19):e2200090
Molecular nutrition & food research 2022 Oct;66(19):e2200090
Tumor suppressor DEAR1 regulates mammary epithelial cell fate and predicts early onset and metastasis in triple negative breast cancer.
Le UQ, Chen N, Balasenthil S, Lurie E, Yang F, Liu S, Rubin L, Solis Soto LM, Raso MG, Batra H, Sahin AA, Wistuba II, Killary AM
Scientific reports 2022 Nov 14;12(1):19504
Scientific reports 2022 Nov 14;12(1):19504
The sodium/glucose cotransporters as potential therapeutic targets for CF lung diseases revealed by human lung organoid swelling assay.
Hirai H, Liang X, Sun Y, Zhang Y, Zhang J, Chen YE, Mou H, Zhao Y, Xu J
Molecular therapy. Methods & clinical development 2022 Mar 10;24:11-19
Molecular therapy. Methods & clinical development 2022 Mar 10;24:11-19
EMP3 negatively modulates breast cancer cell DNA replication, DNA damage repair, and stem-like properties.
Zhou K, Sun Y, Dong D, Zhao C, Wang W
Cell death & disease 2021 Sep 12;12(9):844
Cell death & disease 2021 Sep 12;12(9):844
miR-34a mimic or pre-mir-34a, which is the better option for cancer therapy? KatoIII as a model to study miRNA action in human gastric cancer cells.
Jafari N, Abediankenari S, Hossein-Nataj H
Cancer cell international 2021 Mar 19;21(1):178
Cancer cell international 2021 Mar 19;21(1):178
Nicotine promotes breast cancer metastasis by stimulating N2 neutrophils and generating pre-metastatic niche in lung.
Tyagi A, Sharma S, Wu K, Wu SY, Xing F, Liu Y, Zhao D, Deshpande RP, D'Agostino RB Jr, Watabe K
Nature communications 2021 Jan 20;12(1):474
Nature communications 2021 Jan 20;12(1):474
Targeting Mitochondria-Located circRNA SCAR Alleviates NASH via Reducing mROS Output.
Zhao Q, Liu J, Deng H, Ma R, Liao JY, Liang H, Hu J, Li J, Guo Z, Cai J, Xu X, Gao Z, Su S
Cell 2020 Oct 1;183(1):76-93.e22
Cell 2020 Oct 1;183(1):76-93.e22
Chemotherapeutic Stress Influences Epithelial-Mesenchymal Transition and Stemness in Cancer Stem Cells of Triple-Negative Breast Cancer.
Li X, Strietz J, Bleilevens A, Stickeler E, Maurer J
International journal of molecular sciences 2020 Jan 8;21(2)
International journal of molecular sciences 2020 Jan 8;21(2)
FZD5 contributes to TNBC proliferation, DNA damage repair and stemness.
Sun Y, Wang Z, Na L, Dong D, Wang W, Zhao C
Cell death & disease 2020 Dec 12;11(12):1060
Cell death & disease 2020 Dec 12;11(12):1060
Human colorectal cancer cells frequently express IgG and display unique Ig repertoire.
Geng ZH, Ye CX, Huang Y, Jiang HP, Ye YJ, Wang S, Zhou Y, Shen ZL, Qiu XY
World journal of gastrointestinal oncology 2019 Mar 15;11(3):195-207
World journal of gastrointestinal oncology 2019 Mar 15;11(3):195-207
Profiling human breast epithelial cells using single cell RNA sequencing identifies cell diversity.
Nguyen QH, Pervolarakis N, Blake K, Ma D, Davis RT, James N, Phung AT, Willey E, Kumar R, Jabart E, Driver I, Rock J, Goga A, Khan SA, Lawson DA, Werb Z, Kessenbrock K
Nature communications 2018 May 23;9(1):2028
Nature communications 2018 May 23;9(1):2028
Evidence of In Vitro Preservation of Human Nephrogenesis at the Single-Cell Level.
Pode-Shakked N, Gershon R, Tam G, Omer D, Gnatek Y, Kanter I, Oriel S, Katz G, Harari-Steinberg O, Kalisky T, Dekel B
Stem cell reports 2017 Jul 11;9(1):279-291
Stem cell reports 2017 Jul 11;9(1):279-291
TGF-β1 secreted by Tregs in lymph nodes promotes breast cancer malignancy via up-regulation of IL-17RB.
Huang SC, Wei PC, Hwang-Verslues WW, Kuo WH, Jeng YM, Hu CM, Shew JY, Huang CS, Chang KJ, Lee EY, Lee WH
EMBO molecular medicine 2017 Dec;9(12):1660-1680
EMBO molecular medicine 2017 Dec;9(12):1660-1680
A cell transportation solution that preserves live circulating tumor cells in patient blood samples.
Stefansson S, Adams DL, Ershler WB, Le H, Ho DH
BMC cancer 2016 May 6;16:300
BMC cancer 2016 May 6;16:300
Solitomab, an EpCAM/CD3 bispecific antibody construct (BiTE®), is highly active against primary uterine and ovarian carcinosarcoma cell lines in vitro.
Ferrari F, Bellone S, Black J, Schwab CL, Lopez S, Cocco E, Bonazzoli E, Predolini F, Menderes G, Litkouhi B, Ratner E, Silasi DA, Azodi M, Schwartz PE, Santin AD
Journal of experimental & clinical cancer research : CR 2015 Oct 17;34:123
Journal of experimental & clinical cancer research : CR 2015 Oct 17;34:123
Solitomab, an epithelial cell adhesion molecule/CD3 bispecific antibody (BiTE), is highly active against primary chemotherapy-resistant ovarian cancer cell lines in vitro and fresh tumor cells ex vivo.
English DP, Bellone S, Schwab CL, Roque DM, Lopez S, Bortolomai I, Cocco E, Bonazzoli E, Chatterjee S, Ratner E, Silasi DA, Azodi M, Schwartz PE, Rutherford TJ, Santin AD
Cancer 2015 Feb 1;121(3):403-12
Cancer 2015 Feb 1;121(3):403-12
The isolation and characterization of CTC subsets related to breast cancer dormancy.
Vishnoi M, Peddibhotla S, Yin W, T Scamardo A, George GC, Hong DS, Marchetti D
Scientific reports 2015 Dec 3;5:17533
Scientific reports 2015 Dec 3;5:17533
Clostridium perfringens enterotoxin C-terminal domain labeled to fluorescent dyes for in vivo visualization of micrometastatic chemotherapy-resistant ovarian cancer.
Cocco E, Shapiro EM, Gasparrini S, Lopez S, Schwab CL, Bellone S, Bortolomai I, Sumi NJ, Bonazzoli E, Nicoletti R, Deng Y, Saltzman WM, Zeiss CJ, Centritto F, Black JD, Silasi DA, Ratner E, Azodi M, Rutherford TJ, Schwartz PE, Pecorelli S, Santin AD
International journal of cancer 2015 Dec 1;137(11):2618-29
International journal of cancer 2015 Dec 1;137(11):2618-29
NDY1/KDM2B functions as a master regulator of polycomb complexes and controls self-renewal of breast cancer stem cells.
Kottakis F, Foltopoulou P, Sanidas I, Keller P, Wronski A, Dake BT, Ezell SA, Shen Z, Naber SP, Hinds PW, McNiel E, Kuperwasser C, Tsichlis PN
Cancer research 2014 Jul 15;74(14):3935-46
Cancer research 2014 Jul 15;74(14):3935-46
GATA3 suppresses metastasis and modulates the tumour microenvironment by regulating microRNA-29b expression.
Chou J, Lin JH, Brenot A, Kim JW, Provot S, Werb Z
Nature cell biology 2013 Feb;15(2):201-13
Nature cell biology 2013 Feb;15(2):201-13
Stem-like epithelial cells are concentrated in the distal end of the fallopian tube: a site for injury and serous cancer initiation.
Paik DY, Janzen DM, Schafenacker AM, Velasco VS, Shung MS, Cheng D, Huang J, Witte ON, Memarzadeh S
Stem cells (Dayton, Ohio) 2012 Nov;30(11):2487-97
Stem cells (Dayton, Ohio) 2012 Nov;30(11):2487-97
Loss of plakoglobin promotes decreased cell-cell contact, increased invasion, and breast cancer cell dissemination in vivo.
Holen I, Whitworth J, Nutter F, Evans A, Brown HK, Lefley DV, Barbaric I, Jones M, Ottewell PD
Breast cancer research : BCR 2012 May 25;14(3):R86
Breast cancer research : BCR 2012 May 25;14(3):R86
Slow-cycling therapy-resistant cancer cells.
Moore N, Houghton J, Lyle S
Stem cells and development 2012 Jul 1;21(10):1822-30
Stem cells and development 2012 Jul 1;21(10):1822-30
Establishment and characterization of a new human pancreatic adenocarcinoma cell line with high metastatic potential to the lung.
Kalinina T, Güngör C, Thieltges S, Möller-Krull M, Penas EM, Wicklein D, Streichert T, Schumacher U, Kalinin V, Simon R, Otto B, Dierlamm J, Schwarzenbach H, Effenberger KE, Bockhorn M, Izbicki JR, Yekebas EF
BMC cancer 2010 Jun 16;10:295
BMC cancer 2010 Jun 16;10:295
Exploration of target molecules for prostate cancer gene therapy.
Suzuki K, Nakamura K, Kato K, Hamada H, Tsukamoto T
The Prostate 2007 Aug 1;67(11):1163-73
The Prostate 2007 Aug 1;67(11):1163-73
Expression of epithelial cell adhesion molecule in carcinoma cells present in blood and primary and metastatic tumors.
Rao CG, Chianese D, Doyle GV, Miller MC, Russell T, Sanders RA Jr, Terstappen LW
International journal of oncology 2005 Jul;27(1):49-57
International journal of oncology 2005 Jul;27(1):49-57
Evidence for a role of the epithelial glycoprotein 40 (Ep-CAM) in epithelial cell-cell adhesion.
Litvinov SV, Bakker HA, Gourevitch MM, Velders MP, Warnaar SO
Cell adhesion and communication 1994 Oct;2(5):417-28
Cell adhesion and communication 1994 Oct;2(5):417-28
Ep-CAM: a human epithelial antigen is a homophilic cell-cell adhesion molecule.
Litvinov SV, Velders MP, Bakker HA, Fleuren GJ, Warnaar SO
The Journal of cell biology 1994 Apr;125(2):437-46
The Journal of cell biology 1994 Apr;125(2):437-46
No comments: Submit comment
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Staining of A549 human lung carcinoma cell line with Mouse IgG1 kappa Isotype Control PE (Product # 12-4714-82) (blue histogram) or Anti-Human CD326 (EpCAM) PE (purple histogram). Total viable cells were used for analysis.
- Conjugate
- Yellow dye
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- NULL
- Conjugate
- Yellow dye
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- NULL
- Conjugate
- Yellow dye
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- NULL
- Conjugate
- Yellow dye
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- NULL
- Conjugate
- Yellow dye
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- NULL
- Conjugate
- Yellow dye
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- NULL
- Conjugate
- Yellow dye
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Fig. 5 FZD5 maintains stem cell-like properties. A CD133, EPCAM, ALDH1A2, and POU5F1 expression in MDA-MB-231 cells was detected by real-time PCR. B Fractions of CD133-positive and EPCAM-positive MDA-MB-231 cells were detected by flow cytometry. C Mammosphere formation of MDA-MB-231 cells was shown. Scale bar: 500 mum, mean +- SD, n = 3. * P < 0.05, ** P < 0.01, *** P < 0.001, vs. shCtrl. D CD133, EPCAM, ALDH1A2, and POU5F1 expression in Hs-578t cells was detected by real-time PCR. E Fractions of CD133-positive and E PCAM-positive Hs-578t cells were detected by flow cytometry. F Mammosphere formation of Hs-578t cells was shown. Scale bar: 500 mum, mean +- SD, n = 3. * P < 0.05, ** P < 0.01, *** P < 0.001, vs. OE Ctrl.
- Conjugate
- Yellow dye
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Figure 1 Multiparametric flow cytometry of PBMCs capturing uPAR/int beta1 CTC subsets. Breast cancer PBMCs were first sorted applying gating parameters to select for DAPI - (4', 6-diamidino-2-phenylindole)/EpCAM - /CD45 - /CD44 + /CD24 - cells. Cells were then subsequently sorted to obtain uPAR/int beta1 subsets containing combinatorial expression of these markers. Antibodies used for flow cytometry and cell sorting were: anti-human CD45-APC-Cy7 (Biolegend, cat # 304015, 1:50 dilution), mouse anti-human EpCAM-PE CD326 (eBiosciences, cat # 12-9326-71, 1:40 dilution), anti-human CD24-PE ML5 (Biolegend, cat # 311106, 1:20 dilution), anti-human CD44-PE-Cy7 IM7 (Biolegend, cat # 103030, 1:20 dilution), mouse anti-human uPAR (CD87)-FITC (AbD Serotec cat # MCA2506FT, 1:10 dilution), anti-human int beta1 (CD29)-ApC TS2/16 (Biolegend, cat # 3030008, 1:50 dilution). Cells were confirmed to be CTCs by performing RT-PCR, immunoflurescence and genotyping arrays. Representative images are shown.
- Conjugate
- Yellow dye
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Figure 8 Elevated IL-17RB expression in cancer cells derived from tumor-draining lymph nodes in breast cancer patients correlates with aggressive growth nature A Freshly collected human breast cancer (hBC) specimens (PT, primary tumors; LN, paired LN metastasis from the same breast cancer patient) were digested with collagenase-containing buffer overnight. Depletion of hematopoietic cells by CD45 Dynabeads (Invitrogen) enriched the EpCAM + cells for following xenografts. Percentages of EpCAM + cells in human primary breast cancer cells were confirmed by FACS analysis (left two panels: before enrichment; right two panels: after enrichment). All of the histograms were shown that they were EpCAM expressing (black line), compared to isotype control (gray filled). B Tumorigenesis assay was determined in NOD/SCID/IL2Rgamma mice orthotopically injected with hBC PT and hBC LN cells. Representative data on day 180 were shown. White arrow: Orthotopic injection site. C Dot plot illustrated the tumor volumes of hBC PT and hBC LN cell-injected NOD/SCID/IL2Rgamma mice on day 180 ( n = 11). All tumors were confirmed by pan-keratin IHC staining of fat pad sections. D, E H&E stainings and IHC stainings of pan-keratin were shown in the representative cases of fat pad sections from (B). Scale bar: 1 mm (left panels), 100 mum (right panels). F IHC stainings of IL-17RB were shown in the representative cases of fat pad sections from (B). Scale bar: 10 mum. G The correlatio
- Conjugate
- Yellow dye
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Fig. 4 EMP3 interferes with stem-like properties. A CCLE database was interrogated for EMP3, SOX2, CD133, and EPCAM expression. Correlation between two genes in a total of 57 breast cancer cell lines was analyzed by Pearson statistics. B SOX2, CD133, and EPCAM expression in MDA-MB-231 cells were detected by real-time PCR. Mean +- SD, n = 3. * P < 0.05, ** P < 0.01, *** P < 0.001, vs. shCtrl. C Fractions of CD133-positive MDA-MB-231 cells were detected by flow cytometry. Mean +- SD, n = 3. ** P < 0.01, vs. shCtrl. D Fractions of EPCAM-positive MDA-MB-231 cells were detected by flow cytometry. Mean +- SD, n = 3. ** P < 0.01, vs. shCtrl. E Mammosphere formation of MDA-MB-231 cells was shown. Mean +- SD, n = 3. ** P < 0.01, *** P < 0.001, vs. shCtrl. F Mammosphere formation of MCF7 cells was shown. Mean +- SD, n = 3. ** P < 0.01, vs. OE Ctrl. G SOX2, CD133, and EPCAM expression in MCF7 cells were detected by real-time PCR. Mean +- SD, n = 3. *** P < 0.001, vs. OE Ctrl.
- Conjugate
- Yellow dye
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Figure 1 Generation of proximal lung organoids from cystic fibrosis patient iPSCs (A) Schematic representation of lung organoid differentiation protocol from human iPSCs (hiPSCs). (B) Representative immunofluorescence staining for p63 (green), NKX2.1 (red), SOX2 (red), and nuclear protein expression with DNA stain (DAPI; blue) in HLOs on day 20 (p63 and NKX2.1) and day 22 (SOX2). Scale bars represent 100 mum. (C) Flow cytometry analysis of EpCAM expression in organoid cells on day 23. Left: summary percentage of EpCAM-positive cells. Three independent HLO plates were used for the experiment. Data are presented as mean +- standard error of the mean (SEM). Right: a representative flow cytometry result. The x axis indicates the count of cells, and the y axis indicates EpCAM signal level.
- Conjugate
- Yellow dye
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Fig. 1 Identification of three major epithelial cell types and their markers using scRNAseq. a Overview of scRNAseq approach using primary human breast tissue samples that were processed into single cell suspension, followed by FACS isolation of basal (CD49f-hi, EPCAM+) and luminal (CD49f+, EPCAM-hi), and scRNAseq analysis using the microfluidics-enabled scRNAseq. b Combined tSNE projection of cells from all three microfluidics-enabled scRNAseq datasets. The major basal cluster is highlighted in red; Luminal1 (L1) in green; Luminal2 (L2) in blue. c Heatmap displaying the scaled expression patterns of top marker genes within each cell type with selected marker genes highlighted; yellow indicating high expression of a particular gene, and purple indicating low expression. d Feature plots showing the scaled expression of TCF4 and ZEB1 marking a subpopulation of basal cells and gene plot showing co-expression of TCF4 and ZEB1 in the same cells. See Supplementary Fig. 1 capture site imaging, gene detection, individual principal component analysis, tSNE plot colored by individual-derived cells and feature plots of cell type-specific markers
- Conjugate
- Yellow dye
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Figure 1 Characterization of BCSC5 in vitro and in vivo. ( A ) Representative pictures of BCSC5 cultured in 3D and 2D conditions, scale bar 100 mum. ( B ) Sphere-forming capacity of BCSC5 cells in an anchorage-independent growth assay ( n = 3). Data represent means + SEM. ( C , D ) Expression patterns of CD24 and CD44 ( C ) as well as EpCAM and CD49f ( D ) in BCSC5 cells analyzed by flow cytometry. ( E ) Tumor formation in limiting dilution xenografts of BCSC5. ( F ) Representative growth curves for limiting dilution assay of BCSC5 xenografts in immunocompromised NOD/SCID mice. ( G ) Immunohistochemical (IHC) analysis of ER, PR, and HER2 on sections of the BCSC5 xenograft tumors, scale bar 100 mum.
- Conjugate
- Yellow dye